Publication | Closed Access

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial

Metabolic SyndromeDiabetes ManagementRenal FunctionRandomised TrialDiabetesPharmacologyChronic Kidney DiseaseType 2Diabetic Kidney DiseaseInsulin ManagementDiabetes MellitusMedicine